Pilot study of changes in the level of piRNA in plasma and serum in women at different stages of physiological pregnancy

Aim. To study changes in the level of piRNA in plasma and serum of pregnant women at different stages of gestation.
Material and Methods. A total of 42 samples of plasma and blood serum were obtained from seven women with physiological singleton pregnancy without obstetric and gynecological pathology. The study was carried out at three time points corresponding to 8–13, 18–25, and 30–35 weeks of pregnancy, respectively. To assess the spectrum and levels of piRNA by the NGS method, whole genome sequencing of small RNAs was carried out. Sequencing data analysis was performed using the GeneGlobe Data Analysis Center web application. Differential expression was assessed using the DESeq2 R package.
Results and Discussion. The piRNA contents among all small RNAs were 2.29%, 2.61%, and 4.16% in plasma and 7.29%, 7.02%, and 10.82% in serum during the first, second, and third trimesters, respectively. The contents of the following piRNAs increased in blood plasma from the first to the third trimester: piR 000765, piR 020326, piR 019825, piR 020497, piR 015026, piR 001312, and piR 017716. The study showed that the levels of piR 000765, piR 020326, piR 019825, piR 015026, piR 020497, piR 001312, piR 017716, and piR 004153 were significantly higher in serum compared with the corresponding values in plasma whereas the content of only one molecule, piR 018849, was higher in plasma.
Conclusion. This pilot work created a basis for understanding the processes of piRNA expression in plasma and serum of pregnant women and can become the foundation for the search for biomarkers of various complications in pregnancy.

1. Watson C.N., Belli A., Di Pietro V. Small non-coding RNAs: New class of biomarkers and potential therapeutic targets in neurodegenerative disease. Front. Genet. 2019;10:364. DOI: 10.3389/fgene.2019. 00364.

2. Guarino E., Delli Poggi C., Grieco G.E., Cenci V., Ceccarelli E., Crisci I. et al. Circulating мicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives. Int. J. Endocrinol. 2018;2018:6380463. DOI: 10.1155/2018/6380463.

3. Vashukova E.S., Glotov A.S., Fedotov P.V., Efimova O.A., Pakin V.S., Mozgovaya E.V. et al. Placental microRNA expression in pregnancies complicated by superimposed preeclampsia on chronic hypertension. Mol. Med. Rep. 2016;14(1):22–32. DOI: 10.3892/mmr.2016.5268.

4. Hromadnikova I., Kotlabova K., Ivankova K., Krofta L. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLoS One. 2017;12(2):e0171756. DOI: 10.1371/journal.pone.0171756.

5. Rayford K.J., Cooley A., Rumph J.T., Arun A., Rachakonda G., Villalt F. et al. piRNAs as modulators of disease pathogenesis. Int. J. Mol. Sci. 2021;22(5):2373. DOI: 10.3390/ijms22052373.

6. Jia S., Zhang Q., Wang Y., Wang Y., Liu D., He Y. et al. PIWI-interacting RNA sequencing profiles in maternal plasma-derived exosomes reveal novel non-invasive prenatal biomarkers for the early diagnosis of nonsyndromic cleft lip and palate. EBioMedicine. 2021;65:103253. DOI: 10.1016/j.ebiom.2021.103253.

7. Timofeeva A.V., Chagovets V.V., Drapkina Y.S., Makarova N.P., Kalinina E.A., Sukhikh G.T. Cell-free, embryo-specific sncRNA as a molecular biological bridge between patient fertility and IVF efficiency. Int. J. Mol. Sci. 2019;20(12):2912. DOI: 10.3390/ijms20122912.

8. Zharikova A.A., Mironov A.A. PiRNAs: Biology and bioinformatics. Molecular Biology. 2016;50(1):69–76 (In Russ.). DOI: 10.7868/S0026898416010225.

9. Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. DOI: 10.1186/s13059-014-0550-8.

10. Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological). 1995;57(1):289–300. DOI: 10.2307/2346101.

11. Veneziano D., Nigita G., Ferro A. Computational approaches for the analysis of ncRNA through deep sequencing techniques. Front. Bioeng. Biotechnol. 2015;3:77. DOI: 10.3389/fbioe.2015.00077.

12. Yang X., Cheng Y., Lu Q., Wei J., Yang H., Gu M. Detection of stably expressed piRNAs in human blood. Int. J. Clin. Exp. Med. 2015;8(8):13353–13358.

13. Mompeón A., Ortega-Paz L., Vidal-Gómez X., Costa T.J. Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis. Sci. Rep. 2020;10(1):5373. DOI: 10.1038/s41598-020-61507-z.

14. Illarionov R.A., Kosyakova O.V., Vashukova E.S., Yurkina N.O., Bakleicheva M.O., Dolgova Yu.S. et al. Collection of samples from women at diff erent stages of pregnancy to search for early biomarkers of preterm birth. Cardiovascular Therapy and Prevention. 2020;19(6):2708 (In Russ.). DOI: 10.15829/1728-8800-2020-2708.

15. Krishnan P., Ghosh S., Wang B., Heyns M., Li D., Mackey J.R. et al. Genome-wide profi ling of transfer RNAs and their role as novel prognostic markers for breast cancer. Sci. Rep. 2016;6:32843. DOI: 10.1038/srep32843.

16. Wang A., Liu J., Zhuang X., Yu S., Zhu S., Liu Y. et al. Identifi cation and comparison of piRNA expression profi les of exosomes derived from human stem cells from the apical papilla and bone marrow mesenchymal stem cells. Stem Cells Dev. 2020;29(8):511–520. DOI: 10.1089/scd.2019.0277.

17. El-Mogy M., Lam B., Haj-Ahmad T.A., McGowan S., Yu D., Nosal L. et al. Diversity and signature of small RNA in diff erent bodily fl uids using next generation sequencing. BMC Genomics. 2018;19(1):408. DOI: 10.1186/s12864-018-4785-8.

18. Yuan T., Huang X., Woodcock M., Du M., Dittmar R., Wang Y. et al. Plasma extracellular RNA profi les in healthy and cancer patients. Sci. Rep. 2016;6:19413. DOI: 10.1038/srep19413.

19. Singh K.P., Maremanda K.P., Li D., Rahman I. Exosomal microRNAs are novel circulating biomarkers in cigarette, waterpipe smokers, E-cigarette users and dual smokers. BMC Med. Genomics. 2020;13(1):128. DOI: 10.1186/s12920-020-00748-3.

20. Timofeeva A., Drapkina Y., Fedorov I., Chagovets V., Makarova N., Shamina M. et al. Small noncoding RNA signatures for determining the developmental potential of an embryo at the morula stage. Int. J. Mol. Sci. 2020;21(24):9399. DOI: 10.3390/ijms21249399.